Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease
- 12 February 2024
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 224, 107533
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (GNT1116371, GNT2015613)
- Lung Foundation Australia
This publication has 17 references indexed in Scilit:
- Treatment of fibrotic interstitial lung disease: current approaches and future directionsThe Lancet, 2021
- The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort StudyRespiration, 2021
- Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesNew England Journal of Medicine, 2019
- Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung DiseaseLung, 2018
- The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaRespirology, 2017
- The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung diseaseRespiratory Medicine, 2017
- Unclassifiable interstitial lung diseases: Clinical characteristics and survivalRespirology, 2016
- Long-term follow-up high-resolution CT findings in non-specific interstitial pneumoniaThorax, 2010
- Epidemiology of interstitial lung diseases in GreeceRespiratory Medicine, 2009
- Interstitial lung diseases: characteristics at diagnosis and mortality risk assessmentRespiratory Medicine, 2004